US 10857231
Formulations of VEG antagonist fusion proteins and method of manufacturing them
granted A61KA61K31/4172A61K31/7012
Quick answer
US patent 10857231 (Formulations of VEG antagonist fusion proteins and method of manufacturing them) held by REGENERON PHARMACEUTICALS, INC. expires Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Dec 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 114
- CPC classes
- A61K, A61K31/4172, A61K31/7012, A61K38/16, A61K38/179